NPA objects to liquid supplement guidance
This article was originally published in The Tan Sheet
FDA may violate the Administrative Procedures Act by apparently changing enforcement discretion policy regarding liquid dietary supplement products, according to the Natural Products Association. FDA's stance in a December 2009 draft guidance that some liquid products labeled as supplements may be conventional beverages should be promulgated through notice-and-comment rulemaking, NPA VP of Scientific & Regulatory Affairs Daniel Fabricant says in a Feb. 2 1letter. NPA asks FDA as it finalizes the guidance to say why it rejects or accepts comments. The trade group adds the guidance lacks "a verifiable or scientific standard" to delineate supplement and conventional food packaging - a point other stakeholders make (2"The Tan Sheet" Feb. 8, 2010)
You may also be interested in...
An FDA guidance document conflicts with the Dietary Supplement Health and Education Act and agency precedent by questioning the classification of liquid products labeled as supplements, according to industry comments
Frank Zhang, co-founder and chair of the Hong Kong-listed Chinese biotech Genscript, parent of Nasdaq-listed cell therapy star, Legend Biotech, has been detained by Chinese authorities, along with four employees.
Tests used to detect cytomegalovirus in organ transplant patients may face an easier path to market under a proposed rule that the US Food and Drug Administration released on 18 September. See what the regulatory agency said about it here.